Data/hora: 05/06/2024 16:45:20

Provedor de dados: 	65	
País: 	Brazil	
Título: 	Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of therapeutic drugs	
Autores: 	Linardi,Renata Lehn; Natalini,Cláudio Corrêa.	
Data: 	2006-02-01	
Ano: 	2006	
Palavras-chave: 	MDR1 gene; P-glycoprotein; Therapeutics; Pharmacology.	
Resumo: 	(MDR1) gene expressed in tumor cells and also in several normal tissues, such as intestine, liver, kidney, blood-brain barrier, spinal cord, and placenta. P-gp has been identified in mice, rat, bovine, monkey, rodents, and human beings and has been receiving a particular clinical relevance because this protein expression limits brain access and intestinal absorption of many drugs. This protein plays a role as a protective barrier against a wide variety of substrates, avoiding drug entry into the central nervous system. P-glycoprotein also interferes with drug bioavailability and disposition, including absorption, distribution, metabolization, and excretion, influencing pharmacokinetic and pharmacodynamic of drugs. Modulation of P-gp may help the efficacy of treatment of several diseases and can explain some adverse central nervous system effects induced by drugs after intravenous administration and the poor response of oral administration in patients. Alteration in P-gp expression or function has been associated with several diseases susceptibility in humans and animals. Furthermore, additional studies relating MDR1 and P-gp expression has an important clinical implication also in terms of treatment efficacy.	
Tipo: 	Info:eu-repo/semantics/article	
Idioma: 	Inglês	
Identificador: 	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782006000100056	
Editor: 	Universidade Federal de Santa Maria	
Relação: 	10.1590/S0103-84782006000100056	
Formato: 	text/html	
Fonte: 	Ciência Rural  v.36 n.1 2006	
Fonte: 	info:eu-repo/semantics/openAccess